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ABSTRACT
APPLYING MACHINE LEARNING ALGORITHMS FOR THE ANALYSIS OF
BIOLOGICAL SEQUENCES AND MEDICAL RECORDS
SHAOPENG GU
2019
The modern sequencing technology revolutionizes the genomic research and
triggers explosive growth of DNA, RNA, and protein sequences. How to infer the
structure and function from biological sequences is a fundamentally important task in
genomics and proteomics fields. With the development of statistical and machine
learning methods, an integrated and user-friendly tool containing the state-of-the-art data
mining methods are needed. Here, we propose SeqFea-Learn, a comprehensive Python
pipeline that integrating multiple steps: feature extraction, dimensionality reduction,
feature selection, predicting model constructions based on machine learning and deep
learning approaches to analyze sequences. We used enhancers, RNA N6methyladenosine sites and protein-protein interactions datasets to evaluate the validation
of the tool. The results show that the tool can effectively perform biological sequence
analysis and classification tasks.
Applying machine learning algorithms for Electronic medical record (EMR) data
analysis is also included in this dissertation. Chronic kidney disease (CKD) is prevalent
across the world and well defined by an estimated glomerular filtration rate (eGFR). The
progression of kidney disease can be predicted if future eGFR can be accurately
estimated using predictive analytics. Thus, I present a prediction model of eGFR that was
built using Random Forest regression. The dataset includes demographic, clinical and
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laboratory information from a regional primary health care clinic. The final model
included eGFR, age, gender, body mass index (BMI), obesity, hypertension, and diabetes,
which achieved a mean coefficient of determination of 0.95. The estimated eGFRs were
used to classify patients into CKD stages with high macro-averaged and micro-averaged
metrics.
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CHAPTER 1: Introduction for Sequencing Data Analysis
1.1 Next-Generation Sequencing
The appearance of next-generation sequencing (NGS) technology has
significantly improved the quantities and qualities of biological sequences [1]. NGS
provides advanced technology with many advantages: ultra-high throughput, speed,
scalability and friendlily cost [2]. With NGS, the duration for sequencing an entire human
genome is reduced from a decade to a single day [3] and its cost dropped from $300000
to less than $1000 [4]. The most recent released version, 232 of GenBank in NCBI
contains 213,387,758 sequences and WGS in NCBI includes 1,022,913,321 sequences
[5]. Analyzing biological sequences help researches to explore the structural and
functional properties of sequences [6, 7], disease diagnosis [8-10], drug target
development, biotechnology [11] and many others.
1.2 Machine Learning in Sequencing Data Analysis
Computational biological sequences analysis tools are urgently needed because an
ever-widening gap emerges between these data and their annotations. Recently, applying
machine learning algorithms for the analysis of biological sequences became a popular
trend [12]. In essence, many problems can be considered as a binary or multi-class
prediction tasks [13, 14], include DNA N6-methyladenosine site [15, 16], RNA N6methyladenosine site [17], RNA-binding protein identification [18], protein function site
[19], protein fold recognition [20, 21], protein-protein interaction prediction [22-24], etc.
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1.3 Feature Extraction of Sequencing Data
Billions of short raw reads are generated for each sample through NGS in FASTA
data format [25], which cannot directly be used for classification purposes. Thus, the step
of feature extraction is required to transform reads of sequences to the mathematical data
matrix using different approaches based on sequencing, physicochemical, evolutional and
structural properties [26].
1.4 Feature Selection
With an increasing number of classification algorithms has been introduced,
selecting the most important features to reach accurate and efficient performances
becomes a new challenge [27]. Some extracted feature vectors show high dimensionality,
which can cause time-consuming and overfitting issues. Therefore, selecting those
features that contribute most to classification is an essential step in the sequencing data
analysis [28]. Some powerful feature selection algorithms that can be used include the
Chi-squared test [29], SVM-RFE [30], Lasso [31], Pearson correlation [32], ReliefF [33],
and so on.
1.5 Dimensionality Reduction
Besides many supervised methods, some unsupervised learning methods such as
K-means [34], PCA [35] and TSNE [36], are introduced. Dimensionality reduction can
project raw feature space with high dimensionality to a new feature space via the linear or
non-linear combination. Dimensionality reduction and feature selection both can reduce
the model’s complexity, computational resource cost and execution time, prevent
overfitting issue and improve the accuracy of prediction to provide more reliable
predictions.
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1.6 Model Construction
Classification is a supervised learning approach to classify new observations
based on the given data in machine learning. Some popular and well-developed
classification algorithms are widely used in many different fields, such as SVM [37],
RandomForest [38], LightGBM [39], XGBoost [40], Adaboost [41] and KNN [42], etc.
Every classifier has its characters thus there is not a best classifier but only an appropriate
classifier. Therefore, training multiple classifiers simultaneously can help researchers to
find the best classifier.
1.7 Sequencing Data Analysis Tool
There are several computational tools are available in the public. Some tools
focus only on extracting features from one or more types of sequencing data. For
instance, repDNA [43], Pse-in-one 2.0 [44], PyFeat [45] and PROFEAT [46] are tools
only for feature extraction. To my knowledge, there are three computational tools:
IFeature [47], iLeran [48] and BioSeq-Analysis2.0 [49] that integrating multiple steps for
sequencing data analysis, but the integrated classifiers and feature selection methods are
not sufficient and updated. In addition, deep learning is a very powerful computational
tool for classification tasks via layer by layer learning [50]. Some popular deep learning
methods show convincing performances for prediction but they are not included in these
packages [51].
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CHAPTER 2: SeqFea-Learn – An Integrated Python Package for the Analysis of
Biological Sequences
2.1 Overall Design of SeqFea-Learn
To develop a comprehensive pipeline for the classification of biological
sequences, we integrated 20 feature selection methods, 16 dimensionality reduction
methods and 13 classification models. In addition, this tool also contains a total of 60
methods to extract features from DNA, RNA and protein sequences, Figure 1. Compared
with other software packages, SeqFea-Learn has the following advantages:
•

A large variety of feature selection methods, including regularization, statistics,
information, tree, and recursive feature elimination-based approaches.

•

13 classification algorithms include three deep learning approaches.

•

Enhanced graphical visualization of results, including a box plot of classification
accuracy and ROC curves.
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Figure 1. The pipeline of SeqFea-Learn. The Python package contains feature extraction,
feature selection, dimensionality reduction, and model construction from sequences. The
input is the DNA, RNA or protein sequences in the FASTA format. The outputs will
provide generated feature vectors, prediction accuracy comparison, and suggestion of the
best model for researchers.
2.2 Detailed Methods in SeqFea-Learn
The DNA, RNA and protein sequence S with L residues can be regarded as:
S = R1 R2  RL −1 RL

(1)

where RL represents the L-th residue.
2.2.1 Feature Extraction
The step of feature extraction consists of 16 feature extraction methods for DNA
and 12 feature extraction methods for RNA; 32 feature extraction methods for protein
sequences, which are shown in Table 1 and Table 2, respectively.
Table 1. List of 16 DNA feature extraction methods and 12 RNA feature extraction
methods
DNA Feature
Extraction
Methods

RNA Feature
Extraction
Methods

Extraction Method Description

Kmer

Kmer

DNA or RNA sequence are represented as the
occurrence frequencies of k neighboring nucleic
acids [55, 56]

Reverse
Compliment
Kmer
(RCKmer)

Reverse
Compliment
Kmer
(RCKmer)

A variant of Kmer descriptor by removing the
reverse compliment Kmer [55, 57]

Pseudo
Dinucleotide

Pseudo
Dinucleotide

Incorporating the contiguous local sequenceorder and global sequence-order information [58]
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Composition
(PseDNC)

Composition
(PseDNC)

Pseudo k-tuple
Nucleotide
Composition
(PseKNC)

-

Extending the PseDNC by incorporating k-tuple
nucleotide composition [59]

Dinucleotide
Based Auto
Covariance
(DAC)

Dinucleotide
Based Auto
Covariance
(DAC)

Measuring the correlation of the same
physicochemical index between two
dinucleotides separated by lag along the sequence
[60, 61]

Dinucleotide
Based Cross
Covariance
(DCC)

Dinucleotide
Based Cross
Covariance
(DCC)

Measuring the correlation of two different
physicochemical indices between two
dinucleotides separated by lag nucleic acids [60,
61]

Dinucleotide
Based Autocross
Covariance
(DACC)

Dinucleotide
Based Autocross
Covariance
(DACC)

Combining of DAC and DCC [43]

Trinucleotide
Based Auto
Covariance
(TAC)

-

Measuring the correlation of the same
physicochemical index between trinucleotides
separated by lag nucleic acids [43]

Trinucleotide
Based Cross
Covariance
(TCC)

-

Measuring the correlation of two different
physicochemical indices between two
trinucleotides separated by lag nucleic acids [43]

Trinucleotide
Based AutoCross
Covariance
(TACC)

-

Combining of TCC and TACC [43]

Nucleic Acid
Composition
(NAC)

Nucleic Acid
Composition
(NAC)

Calculating the frequency of each nucleic acid
type in nucleotide sequence [48]

Di-Nucleotide
Composition
(DNC)

Di-Nucleotide
Composition
(DNC)

Containing 16 NAC descriptors [48]

Tri-Nucleotide
Composition
(TNC)

Tri-Nucleotide
Composition
(TNC)

Containing 64 NAC descriptors [48]
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zCurve
Mathematical
Formula
(zCurve)

zCurve
Mathematical
Formula
(zCurve)

Calculating three components in three axis in
genomic sequence analysis [45]

MonoKGap
Theoretical
Description
(MonoKGap)

MonoKGap
Theoretical
Description
(MonoKGap)

Calculating features based on the value of kgap
[45]

MonoDiKGap
Theoretical
Description
(MonoDiKGap)

MonoDiKGap
Theoretical
Description
(MonoDiKGap)

Calculating features based on value of 4 ∗kgap
[45]

Table 2. List of 32 Protein feature extraction methods and their description
Protein Feature Extraction

Extraction Method Description

Amino Acid Composition
(AAC)

Calculating the frequencies of 20 kinds of amino
acids [62]

Dipeptide Composition (DC)

transforming the variable length of proteins to fixed
length feature vectors [62]

Composition of K-Spaced
Amino Acid Pairs (CKSAAP)

Extracting important intrinsic correlation
information of protein sequences in
multidimensional space [63-65]

Grouped Dipeptide Composition
(GDC)

A variation of the DPC descriptor which generates
25 descriptors [66]

Grouped Tripeptide Composition Another variation of TPC descriptor which
(GTC)
generates 125 descriptors [66]
Conjoint Triad (CT)

Calculating the frequency of occurrence of each
triad [67]

K-Spaced Conjoint Triad
(KSCTriad)

Combining CT and considers the continuous amino
acid units that are separated by any k residues [68]

Composition (C)

Calculating composition descriptors

Transition (T)

Calculating transition descriptors

Distribution (D)

Calculating distribution descriptors [69-71]
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Encoding Based on Grouped
Weight (EBGW)

Capturing the continuity and discontinuity features
based on grouped weight coding [72]

Auto Covariance (AC)

Measuring the correlation of the same property
between two residues separated by distance of l[73]

Moreau-Broto autocorrelation
(Morean-Broto)

Measuring the physiochemical and position
information between two amino acid [74]

Moran Autocorrelation (Moran)

Measuring the physiochemical information of
adjacent amino acid [75]

Geary Autocorrelation (Geary)

Measuring the physiochemical information and
generate positive values [76, 77]

Quasi-Sequence-Order (QSO)

Obtaining the sequence distribution patters for a
specific physicochemical property [78]

Pseudo-Amino Acid
Composition (PseAAC)

Extracting the physicochemical information and
sequence order information [79, 80]

Amphiphilic Pseudo-Amino
Acid Composition (APAAC)

Extracting the type-2 pseudo amino acid
composition [79, 80]

Amino Acid Composition PSSM
(ACC-PSSM)

Calculating process of amino acid composition
PSSM [81, 82]

Dipeptide Composition PSSM
(DPC-PSSM)

Extracting the sequence-order information in the
PSSM [82]

Bi-gram PSSM (Bi-PSSM)

Calculating the frequency of the transition between
amino acids [83]

Auto Covariance PSSM (ACPSSM)

Measuring the correlation of the same property
between two residues separated by lag [84]

Pseudo PSSM (PsePSSM)

Calculating the PsePSSM feature vector according
to the pseudo amino acid composition [85]

AB-PSSM

Calculating feature vector based on averaged PSSM
over blocks [86]

Secondary Structure
Composition (SSC)

Calculating feature based normalized count of
frequency of the structural motifs present at the
amino-acid residue positions [87]

Accessible Surface Area
composition (ASA)

Calculating feature based on normalized sum of
accessible surface area [87]

Torsional Angles Composition
(TAC)

Calculating features based four different types of
torsional angles [87]

Torsional Angles bigram (TAbigram)

Calculating feature based on the bigram of the
torsional angles [87]
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Structural Probabilities bigram
(SP-bigram)

Calculating feature based on structural probabilities
for each position of amino acid residue [87]

Torsional Angles AutoCovariance (TAAC)

Calculating feature from the torsional autocovariance [87]

Structural Probabilities AutoCovariance (SPAC)

Calculating feature from the structural probabilities
[87]

2.2.2 Feature Selection and Dimensionality Reduction
SeqFea-Learn integrated steps of feature selection and dimensionality reduction,
which are shown in Table 3.
Table 3. Feature selection and dimensionality reduction methods
Feature
Selection
Method

Description

Dimensionality
Reduction
Method

Description

Lasso

Using Lasso liner model
to recursively eliminate
features [31, 88]

K-means

Clustering data by separating
samples in n groups of equal
variances [34]

ElasticNet Using ElasticNet model
to recursively eliminate
features [89]

T-SNE

Visualizing highdimensional data [36]

L1-SVM

Using SVM with L1
penalty model to
recursively eliminate
features [90]

Principal
Component
Analysis (PCA)

Linear dimensionality
reduction using singular
value decomposition [35]

CHI2

Retrieving best features
based on 𝑥 2 test [91]

Kernel PCA
(KPCA)

Non-linear dimensionality
reduction through use of
kernels [35]

Pearson
Correlatio
n (PC)

Retrieving best features
based on Pearson
correlation [32]

Locally linear
embedding
(LLE)

Reducing projection of data
which preserves distances
within local neighborhoods
[105]

ExtraTree

Using ExtraTree model
to recursively eliminate
features [92]

Truncated
Singular Value
Decomposition
(TSVD)

Linear dimensionality
reduction by means of
truncated singular value
decomposition [106]
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xgBosst

Using xgBoost model to
recursively eliminate
features [93]

Non-negative
matrix
factorization
(NMF)

Reducing dimension by
finding two non-negative
matrix [107]

SVMRFE

Using linear SVM model Multito recursively eliminate
dimensional
features [100]
Scaling (MDS)

Reducing dimension by
modeling data as distances
in a geometric space [108]

LOGRFE

Using Logistic
Regression model to
recursively eliminate
features [94]

Independent
Component
Analysis (ICA)

Reducing dimension by
finding components with
some sparsity [109]

Mutual
Informati
on (MI)

Retrieving best features
based mutual
information [95]

Factor Analysis
(FA)

Reducing dimension by
performing a maximum
likelihood estimate [110]

Minimum
Redundan
cy
Maximum
Relevance
(MRMR)

Selecting features that
still having high
correlation to the
classification variable
[96]

Agglomerate
Feature (AF)

Recursively merges feature
instead of samples [111]

Joint
Mutual
Informati
on (JMI)

Retrieving best features
based joint mutual
information [97]

Gaussian
Reducing the dimension by
Random
projecting the original input
Projection (GRP) space using the Gaussian
distribution [112]

Maximum
Relevance
Maximum
Distance
(MRMD)

Retrieving best features
by measuring relevance
and redundancy between
features [98]

Sparse Random
Projection (SRP)

Reducing dimension by
projecting the original input
space using a sparse random
matrix [113]

ReliefF

Retrieving best features
by calculating and
ranking a feature score
for each feature [33]

Autoencoder

Reducing the dimension
using encode and decode
neural network [114]

Trace
Ratio

Retrieving best features
by calculating the
corresponding score in
trace ratio form [99]

Gaussian Noise
Autoencoder
(GNA)

Corrupting input before
being passed to autoencoder
neural network [115]

Gini
Index

Retrieving best features
by constructing the
measure function based
on Gini-Index [100]

Variational
Autoencoder
(VA)

Neural network can be
trained with stochastic
gradient descent [116]
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Spectral
Feature
Selection
(SPEC)

Retrieving best features
based on structure
induced [101]

-

-

Fisher
Score

Retrieving best features
based on scores of
features under the Fisher
criterion [102]

-

-

T Score

Retrieving best features
based on their t-score
[103]

-

-

Informati
on Gain
(IG)

Retrieving best features
based on their
information gain [104]

-

-

2.2.3 Models Construction
SeqFea-Learn integrated 10 popular classifiers include SVM, KNN, RF,
LightGBM, XGBoost, Adaboost [118], Extra-Tree, Gaussian Naïve Bayes (GNB) [119],
GBDT [117]. The tool also integrated three deep learning methods, including deep neural
network (DNN) [52], convolutional neural network (CNN) [53], and recurrent neural
network (RNN) [54].
2.2.4 Cross-validation and Models Evaluation
Stratified 5-Folds cross-validator is used for obtaining classification accuracy and
plotting ROC curves. All models are evaluated using classification accuracy that reflects
the fraction of correct predictions:

𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑟𝑟𝑒𝑐𝑡 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠

(2)

Most structural and functional of sequences predictions are binary classification and the
accuracy can be calculated by:
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𝑇𝑃+𝑇𝑁

𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 = 𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁

(3)

where TP, TN, FP and FN in the above equations represent true positive, true negative,
false positive and false negative, respectively.
𝑇𝑃(𝑖)+𝑇𝑁(𝑖)

𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 = 𝑇𝑃(𝑖)+𝑇𝑁(𝑖)+𝐹𝑃(𝑖)+𝐹𝑁(𝑖)

(4)

where i means ith classes.
2.3 Application of SeqFea-Learn
Three prediction tasks were performed for DNA, RNA and protein sequences
respectively to evaluate our tool. These classification performances are comparable and
even more effective than the state-of-the-art approaches, which indicate our proposed
python package is competitive for the analysis of biological sequences.
2.3.1 Enhancers Classification
Enhancers play an important role in analyzing gene expression. The dataset
contains we used 1484 enhancer samples and 1484 non-enhancer samples [120]. We
applied five DNA feature extraction methods: PSTNP, Kmer, pseDNC, BE and DNC to
construct predictors. We also found that fusing these feature descriptors as one mixed
descriptor can effectively represent the information and improve classification
performance. The highest AUCs of 13 predictors are shown in Table 4. Compare to
BioSeq-Analysis 2.0 (AUC: 0.82), our tool shows a better classification performance.
Table 4. AUC based on different feature descriptors for enhancer
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Feature
Extraction
Methods

PSTNP Kmer

pseDNC BE

DNC

Five Descriptors
Fusion

Highest
AUC of 13
Predictors

0.90

0.84

0.84

0.83

0.84

0.91

(SVM)

(SVM)

(DNN)

(GNB)

(RNN)

(DNN)

All of 20 feature selection methods are applied to the fused vector. These selected feature
vectors are then used to construct 13 classifiers for finding the best. Based on our
observation, the selected feature vector using the Extra-Tree method can achieve better
prediction performance, Figure 2. The execution time of modeling is significantly
reduced, Table 5.
Table 5. Comparison of number of features and modeling execution time of enhancers
Fused feature vector

Selected feature vector
based Extra-Tree

Number of Features

1296

50

Execution Time

34m 42s

4m 5s

14

A

B

Figure 2. The boxplot of classification accuracies (A) and ROC curves (B) of DNA
enhancers using various classifiers with Extra-Tree feature selection method. (A) 13
classifiers all achieve satisfactory accuracy, and SVM, DNN, RNN obtain superior
performance than other classifiers. (B) The ROC curves of 13 classifier indicate DNN
and RNN achieved better results.
2.3.2 RNA N6-methyladenine Sites Prediction
N6-methyladenosine (m6A) refers to methylation of the adenosine nucleotide acid
at the nitrogen-6 position. It is highly related to a series of biological processes, such as
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splicing events, mRNA exporting, nascent mRNA synthesis, nuclear translocation and
translation process [17]. The m6A dataset contains 2614 sequences, where 1307
represents true methyladenosine sites, and the remaining 1307 are false methyladenosine
sites. BioSeq-Analysis2.0 achieves 0.73 AUC with RandomForest classifier. Similarly,
the fused feature vector shows a better classification performance, Table 6. After the step
of feature selection and model construction, the vector using the ReliefF feature selection
method displays better predictions, Figure 3.
Table 6. AUC based on different feature descriptors for RNA N6-methyladenine sites
Feature
Extraction
Methods

PSTNP

PseDNC

DNC

TNC

MonoKGap

Five
Descriptors
Fusion

Highest AUC
of 13
Predictors

0.88

0.69

0.68

0.71

0.66

0.89

(SVM)

(DNN)

(SVM)

(DNN)

(DNN)

(SVM)

Table 7. Comparison of number of features and modeling execution time of RNA 6mA
data
Fused feature vector

Selected feature vector
based Extra-Tree

Number of Features

186

50

Execution Time

6m 13s

4m 26s

16
A

B

Figure 3. The boxplot accuracies (A) and ROC curves (B) under different classifiers on
RNA N6-methyladenine sites dataset via ReliefF feature selection. (A) The boxplot of 13
classifiers and deep learning methods achieve better performance and the KNN is the
worst. (B) The ROC curves of 13 classifier and DNN, CNN and RNN obtain the best
prediction performance.
2.3.3 Protein-protein interactions prediction
The analysis of protein-protein interactions (PPIs) can help to understand the protein
function, construct the complete interactome and study the signaling pathways. In this
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section, the dataset includes 5594 PPI samples and 5594 non-PPI samples [153]. We
fused CTDC, CTDT, CTDD, EBGW, Geary, PseAAC, PsePSSM, abPSSM to obtain the
feature representation information. After comparing all selected feature vectors’
predicting performances (Table 8 and 9), the MRMR feature selection method shows a
better performance, Figure 4.
Table 8. AUC based on different feature descriptors for protein-protein interactions data
Feature
Extraction
Methods

CTDC

CTDT

EBG
W

Geary

PseAAC

PsePSSM

abPSSM

Five
Descriptors
Fusion

Highest AUC
of 13
Predictors

0.92

0.96

0.96

0.91

0.95

0.96

0.94

0.98

(CNN)

(RF)

(GBDT)

(RNN)

(DNN)

(LightGBM)

(DNN)

(LightGBM)

Table 9. Comparison of number of features and modeling execution time of PPIs
Fused feature vector

Selected feature vector
based MRMR

Number of Features

2066

200

Execution Time

1006m 20s

110m 30s

18

A

B

Figure 4. The boxplot accuracies (A) and ROC curves (B) under different classifiers on
protein-protein interactions dataset via MRMR feature selection. (A) The boxplot of 13
classifiers and LightGBM achieve better performance and the GNB is the worst. (B) The
ROC curves of 13 classifiers and LightGBM and xgBoost obtain the best prediction
performance.
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2.4 Summary and Conclusion
With the rapid increase of DNA, RNA and protein sequences, the analysis and
process of the biological sequences are urgently needed. Therefore, we developed an
intuitive and comprehensive Python package and web server called SeqFea-Learn to
perform steps of feature extraction, feature selection, dimensionality reduction, and
model construction to predict the structure and function of unseen sequences. SeqFeaLearn for the first time integrated 20 types of feature selection methods and 16 kinds of
dimensionality reduction approach to deal with dimensionality disaster and prevent
overfitting issues. It also offers 10 popular classifiers and 3 deep learning frameworks to
satisfy users’ needs. The tool will generate visible results to provide a user clear idea to
compare and select the best classifier. To further test the validity, we perform three
predicting tasks: enhancers, RNA N6-methyladenine sites and protein-protein
interactions prediction. Integrated feature selection and dimensionality reduction methods
reduce as much as 80% modeling time. These classification performances indicate
SeqFea-Learn is an effective and accurate biological sequencing analysis tool compared
with other state-of-the-art approaches.
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CHAPTER 3: Predicting Outcomes of Chronic Kidney Disease from EMR Data Based
on Random Forest Regression
3.1 Chronic Kidney Disease and eGFR
The increasing incidence of chronic kidney disease (CKD) in the United States
and around the world lays an enormous burden on healthcare [121, 122]. By December
2015, there were 703,243 prevalent patients with End Stage Renal Disease (ESRD), with
the unadjusted incident rate of 378 per million [123]. In 2017, there were approximately
500,000 patients on different dialysis modalities (91% are on hemodialysis), 20,000
received transplants [123]. Treatments that are effective in patients with advanced CKD
also increase health care costs and lead to adverse effects [124]. Thus, it is essential to
identify earlier stage CKD and prevent its progression to ESRD [125]. However, the
biggest challenge is that most people do not have any signs or symptoms in the early
stages and go undetected until an advanced stage.
Early identification and targeted intervention of CKD have attracted considerable
attention from clinicians and researchers since both have the potential to reduce the
number of patients progressing to ESRD and lower the mortality rate related to CKD and
associated healthcare costs [126]. With the growing availability of Electronic Medication
Record (EMR) data, various predictive models for disease progression have been
developed to facilitate the decision-making process of health care providers [124, 127,
128]. Choi et al. classified disease progression models into two categories based on the

extent of targeted diseases: models focusing on a specific disease and those focusing on a
broader range of conditions. Among those disease-specific progression models, some are
validating specific hypotheses of disease progression based on experts’ knowledge [124,
129, 130], while others are driven by the application of advanced statistical methods [131-
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133]. Approaches that can be generalized to model the progression of multiple diseases

have been proposed, where statistical methods and machine learning techniques are
widely used [134, 135]. For kidney disease, different models have been developed in
predicting CKD stages to ESRD over time and in predict variations of GFR in patients
[126, 128, 136, 137].
Estimated glomerular filtration rates (eGFRs) have been used in primary care to
assist the early detection and staging of CKD [138, 139]. The eGFR formula [140] is:
𝑆𝐶𝑟

𝑒𝐺𝐹𝑅 = 141 ∗ min (

𝐾

𝛼

𝑆

, 1) ∗ max ( 𝐾𝐶𝑟 , 1)

−1.209

∗ 0.993𝑎𝑔𝑒 ∗ 1.018[𝑖𝑓 𝑓𝑒𝑚𝑎𝑙𝑒] ∗

1.159[𝑖𝑓 𝐴𝑓𝑟𝑖𝑐𝑎𝑛 𝐴𝑚𝑒𝑟𝑖𝑐𝑎𝑛]

(5)

where eGFR (estimated glomerular filtration rate) = mL/min/1.73 m2; SCr (standardized
serum creatinine) = mg/dL, κ = 0.7 (females) or 0.9 (males), α = −0.329 (females) or
−0.411 (males), min = indicates the minimum of SCr/κ or 1, max = indicates the
maximum of SCr/κ or 1, and age = years.
Although routine reporting of eGFR had positive effects in clinical practice,
including prevention of CKD progression and reduction of CKD related complications,
there are still concerns in its negative effects caused by overdiagnosis [138]. Studies have
begun using an alternative measurement, such as eGFR decline derived from eGFR, to
evaluate and predict CKD progression [141, 142]. Researchers investigated the
association between eGFR change and ESRD risk and mortality risk respectively, where
age and gender factors were taken into account [141, 143, 144]. Large eGFR decline were
associated with greater hazard ratios of ESRD in several clinical trials [145, 146].
However, a smaller eGFR changes, which is a reflection of the short-term treatment
effect of kidney disease, is underexamined [141].
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3.2 Machine Learning in EMR Data Analysis
The application of statistical models and machine learning techniques have been
rapidly growing in estimating health and disease outcomes [147]. Cerqueira et
al.developed a model using the Cox proportional hazard regression in predicting the risks
that pre-dialysis pediatric patients progress to ESRD from CKD [128]. Decruyenaere et
al. compared the performances of machine learning methods with logistic regression in
predicting the occurrence of delayed renal graft in renal transplant patients [148]. Their
results showed that support vector machine outperformed logistic regression in terms of
sensitivity. Kumar compared six machine learning classifiers (Random Forest, Sequential
Minimal Optimization, NaiveBayes, Radial Basis Function, Multilayer Perceptron
Classifier, and SimpleLogistic) in CKD classification and identified that Random forest
outperformed the other classifiers [149].
Since GFR is the best test in measuring the level of kidney function [123, 126], the
renal function of a CKD patient can be predicted if their GFR variations can be predicted.
Consequently, the time to reach GFR thresholds corresponding to stages of CKD can be
anticipated. An integrated expert system has been used in predicting future GFR based on
selected clinical variables and demonstrated reliable accuracy [126]. However, there is
still a lack of efficient methods for predicting the individual level timeframe of CKD
progression. Specifically, Random Forest Regression, featured with a reduction in
overfitting and less variance, has not been used to predict the progression of renal
function yet. This study predicted future eGFR values using Random Forest regression
based on real-world EMR data representing the general population in the upper Midwest.
The main aim of this study is to propose an efficient and reliable clinical tool that allows
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us to identify patients at risk of ESRD at an earlier stage. Such a tool can offer primary
care physicians the opportunity to preemptively suggest the preventive strategies that can
attenuate the development of this challenging disease in patients that reside in our
agricultural communities.
3.3 Methods
3.3.1 Data Acquisition
The dataset used in this study comes from real-world clinical data. We built up a
cohort consisting of 120,495 patients aged from 20 to 80 in Sioux Falls, SD, region that
receiving primary care from Sanford Health. By consulting with the nephrologist, we
pulled out data elements influencing GFR variations for this cohort from the
comprehensive Sanford EMR database for years 2009–17. None of the identifiable
information was extracted to protect patients' privacy. We are focusing on the progression
of CKD, so only the “clinical” encounter data was included. Those data elements contain
patients’ eGFR records for years 2009–17, the ICD-10 codes [150] for CKD,
Hypertension, Diabetes, and Obesity, and their demographic information comprising
Age, Gender, and Race. A detailed description of the data elements is given in Table 10.
Table 10. Predictor and covariate data type breakdown
Feature
Predictor
eGFR

Data elements
All clinical encounter eGFR data with testing dates were pulled out
for each patient

Covariates
Age

Continuous

Gender

Categorical

Race/Ethnicity

Categorical
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BMI

Continuous

Hypertension

Flagged for each patient (ICD-10: I10, I11, I12, I13, I15, I16)

Diabetes

Flagged for each patient (ICD-10: E08, E09, E10, E11, E13)

Obesity

Flagged for each patient (ICD-10: E66.9)

3.3.2 Data Pre-processing
The extracted data were formatted into three separate tables: (1) eGFR table with
rows representing patients and columns containing eGFR for multiple years; (2)
Demographic table consisting of demographic information; and (3) Disease table
composed of diagnosis status of hypertension, diabetes, and obesity. The processing of
these data tables is illustrated in Figure 5 and described below.
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Figure 5. Workflow of the data preprocessing, including initial eGFR data, demographic
and disease information, and data merging and filtering. This process resulted in 61,740
samples with 15 variables each.
1. The eGFR table has 120,495 unique patients and 10 columns, each of which
representing eGFR records in years 2009–18. First, the non-numeric eGFR records
(e.g. “>90”)) were considered as missing data and marked as “NA.” For patients with
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more than one eGFR values in a specific year, the median of these values was
calculated and kept for that year in the table.
2. More than 95% eGFR records are missing in 2009 and 2010, so data from these two
years were omitted. Since the data in 2018 was not complete when the data was
extracted, we also excluded the records in this year. Patient lines were removed from
the data if they have no more than three available records from 2011 to 2017. The
final eGFR table has 61,740 unique patients and 7 years eGFR data for each patient
with at least three eGFR values.
3. Next, the different CKD stages were determined by eGFR values in the physical
laboratory. Therefore, the CKD stages true labels were created using eGFR. The
minimum eGFR value in each of the years between 2011 and 2017 was evaluated
first, and then the CKD stages labels were produced based on the following equation:
1. 𝑖𝑓 min 𝑒𝐺𝐹𝑅 ≥ 90
2. 𝑖𝑓 60 ≤ min 𝑒𝐺𝐹𝑅 < 90
𝑃𝑟𝑎𝑐𝑡𝑖𝑐𝑎𝑙 𝐶𝐾𝐷 𝑆𝑡𝑎𝑔𝑒 = 3. 𝑖𝑓 30 ≤ min 𝑒𝐺𝐹𝑅 < 60
4. 𝑖𝑓 15 < min 𝑒𝐺𝐹𝑅 ≤ 30
{ 5. 𝑖𝑓 min 𝑒𝐺𝐹𝑅 ≤ 15

(6)

4. The true labels were also merged into eGFR matrix based on their index (patient ID).
5. The current eGFR matrix includes 61,740 unique patients, and each patient has 7
years eGFR values from 2011 to 2017 and labels for the CKD stage from 1 to 5. The
final data table was created by merging the eGFR table with the demographic table
and the disease table by matching their patient IDs.
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3.4 Construction of Random Forest Regression Model
The longitudinal design of this study enables the estimation the future eGFR value
from the past eGFR values adjusted by clinical covariates. We selected Random Forest
regression as the primary model because of its efficiency and accuracy to predict 1 year,
2 years and 3 years eGFRs from the historical eGFR records between years 2011–14.
Baseline covariates and predictors: The variables included in the analysis were
baseline eGFR, age, gender, ethnicity, body mass index (BMI), hypertension, diabetes,
obesity.
Outcome: eGFR values in the year 2015, 2016, and 2017 were considered as the
outcome variable. This is based on the consensus that GFR is the best measure of kidney
function.
Model development: the inputs of this model are the attributes of the ith patient
denoted by a vector Xi = (xi1,…, xin) which includes eGFR values from multiple years
and other covariates listed in Table 1. The output is the future eGFR for the ith patient
denoted by Gij where j indicating a future year.
In the computational experiment, we used the processed dataset with 61,740
unique patients. For building the model in predicting eGFR of 2015, the patient must
have recorded eGFR in 2015, and at least two recorded eGFR between 2011 and 2014.
Similar requirements were used in predicting eGFR of 2016 and 2017. Other years’
eGFR values were imputed and filled by the median eGFR value of each patient. All
models were built using scikit-learn package [151]. The parameters of Random Forest
Regressor were determined using the grid-search method. Only two parameters, number
of estimators and maximum number of features, were tuned because they can determine
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numbers of trees in forest and how the tree will split and grow. We also randomly split
the dataset and repeat the training process five times with different sets to avoid over
fitting for our models.
3.5 Assessment of model performance
3.5.1 Goodness-of-fit
The model fit of the proposed Random Forest Regression was measured using the
coefficient of determination R2 to show how well the fitted eGFR value approximates the
real eGFR value. R2 is a measure used to represent the percent of variation explained,
i.e., the proportion of variance in the dependent variable that can directly be attributed to
variance in the independent variables. An R2 of 1 would indicate all changes we see in
the dependent variable are caused by changing our independent variables, whereas an R2
of 0 means no such direct impact. We also checked the residual plot since randomly
distributed residuals indicate the model fits the data well.
3.5.2 Discrimination
The estimated eGFR values were used to classify patients into different
CKD stages based on Eq. (1). Both micro-average and macro average were generated to
illustrate the classification accuracy of the Random Forest model.
3.6 Results
In Random Forest regression analysis, the predicting accuracy was enhanced by
optimizing the values of hyperparameters, where the default values and the optimized
values of the hyperparameters were shown in Table 11. The predicted versus observed
eGFR values in years 1–3 were plotted for both the default and optimized
hyperparameters in Figure 6. The R2 was increased from default to optimized
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hyperparameters in each of the three years. The Root of Mean Squared Error (RMSE) in
Figure 6 illustrated that the optimized hyperparameters provided a more accurate
prediction that the default values. It is also worse noticing that the prediction accuracy
decreased over time. With the optimal parameters, we further examined the importance of
the features included in the analysis whose results were given in Figure 7. It is not
surprising that previous eGFR records played essential roles than other features since
eGFR is decreasing continuously over time. Although the information of age and BMI
are considered in estimating GFR using the eGFR formula, predictions based solely on
the previous eGFR are not sufficient. Age and BMI, as illustrated in Figure 7, still
contribute to 4.7–9% to the future three years of eGFR respectively. All the other
features, including Race, Gender, Obesity, Hypertension, and Diabetes, accounted for a
total of 2.7–3.9% of the variances.
Table 11. Hyperparameters used in the Random Forest Regression for the default and
optimized models.
Default

Optimized

# of trees

10

100

Max depth

None

None

Max sample split

2

2

Min samples leaf

1

1

Max features

11

8

Bootstrap

True

True
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Figure 6. Goodness of fit based on 𝑅 2 of the Random Forest Regression model in
predicting eGFR in year 1 to year 3 for the default and optimized models. RMSE
comparison for each year is also provided for the default and optimized models.

Figure 7. Feature importance in predicting eGFR values in years 1-3 using optimized
parameter values in Random Forest Regression.
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3.7 Conclusion and Discussion
In this study, we proposed a model in predicting future eGFR values, which is
based on Random Forest regression that can efficiently learn from the real world EMR
data and accurately predict future patient outcomes. We validated this model on an EMR
dataset extracted from a health system located in the Great Plains. The computational
experiment achieved an average R2 of 0.95 over three years with small variation. And an
88% Macro Recall and a 96% Macro Precision by averaging over three years were
obtained by dividing patients into different CKD stages using estimated eGFRs. Besides,
we identified the crucial features that contribute to the variation of future eGFRs, which
include recent eGFR records, Age and BMI. Therefore, our proposed predictive model of
eGFR has excellent potential to be developed into a clinical decision support tool to assist
doctors in providing preventive advice to patients.
One of the limitations of this work is that only patients with numeric eGFR
records were included, which exclude those patients without CKD symptoms in the study
period. However, those excluded patients can serve as a control group whose clinical
information can be incorporated into the predictive model to adjust the parameter
estimations. Also, the current study only contained historical eGFRs, demographic
characteristics, and relevant disease diagnoses. Studies have shown that an individual's
genetic and phenotypic characteristics both affect their risk in developing kidney disease,
including genetic mutations, a family history, gender, ethnicity, age, obesity,
socioeconomic status, smoking, nephrotoxins, acute kidney injury, diabetes mellitus, and
hypertension [152]. Thus, we are planning to address those issues in future studies to
improve the practicability of the predictive model of eGFR in support of patient care.
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APPENDIX: SeqFea-Learn Tutorial
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